SYRITA HART: Open Payments
NPI 1316315120 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 18 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $302 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Exact Sciences Corporation | 5 | $108 |
| Novo Nordisk Inc | 3 | $85 |
| ABBVIE INC. | 4 | $85 |
| Hologic Sales and Service, LLC | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: CAPLYTA, Cologuard Collection Kit, ZEPBOUND, MOUNJARO, MAVYRET, Wegovy, APTIMA, Ozempic.
Industry payments across NJ — which companies pay providers there.
